A. CHHABRA ET AL: "Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy", SCIENCE TRANSLATIONAL MEDICINE, vol. 8, no. 351, 10 August 2016 (2016-08-10), pages 351ra105-351ra105, XP055432771, US ISSN: 1946-6234, DOI: 10.1126/scitranslmed.aae0501 (B1)

Weiskopf et al. (2013) Improving macrophage responses to therapeutic antibodies by molecular engineering of SIRPa variants, Oncoimmunology 2:0, e25773 (B2)

HO ET AL.: 'Velcro'' Engineering of High Affinity CD 47 Ectodomain as Signal Regulatory Protein a (SIRPa) Antagonists That Enhance Antibody-dependent Cellular Phagocytosis' JOURNAL OF BIOLOGICAL CHEMISTRY vol. 290, 02 April 2015, pages 12650 - 12663, XP055328006 (B1)

JONATHAN T. SOCKOLOSKY ET AL: "Durable antitumor responses to CD47 blockade require adaptive immune stimulation", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES, vol. 113, no. 19, 10 May 2016 (2016-05-10) , pages E2646-E2654, XP055437347, US ISSN: 0027-8424, DOI: 10.1073/pnas.1604268113 (B1)

KIM ET AL.: 'Stimulation with 4-1BB ( CD 137) inhibits chronic graft-versus-host disease by inducing activation-induced cell death of donor CD 4+ T cells' BLOOD vol. 105, no. 5, 02 November 2004, pages 2206 - 13, XP055368556 (B1)

US-A1- 2011 177 104 (B1)

US-A1- 2012 282 174 (B1)

WEISKOPF ET AL.: 'Engineered SIRPa Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies' SCIENCE vol. 341, 30 May 2013, pages 88 - 91, XP055223925 (B1)

WO-A1-2015/069703 (B1)

WO-A1-2016/033201 (B1)

WO-A2-2015/105995 (B1)

XIAOJUAN LIU ET AL: "CD47 blockade triggers T cell-mediated destruction of immunogenic tumors", NATURE MEDICINE, vol. 21, no. 10, 31 October 2015 (2015-10-31), pages 1209-1215, XP055478072, New York ISSN: 1078-8956, DOI: 10.1038/nm.3931 (B1)

Cariad Chester et al: "Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors", Current Opinion in Immunology, vol. 33, 1 April 2015 (2015-04-01), pages 1-8, (B2)

Christopher Lucido et al: "CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance", Vaccines, vol. 2, no. 4 , pages 841-853, (B2)

Gauttier V et al: "Dual targeting of adaptive and innate immune checkpoints induce potent memory anti-tumor response", European Journal of Cancer, vol. 61, 1 January 1900 (1900-01-01), (B2)

Gauttier et al - publication date (July 2016) (B2)

Ho et al. (2013) Targeting SIRPa in cancer, Oncoimmunology 2:2, e23081 (B2)

Houot Roch, Et Al: "Boosting antibody-dependant cellular cytotoxicity against tumor cells with a CD137 stimulatory antibody", OncoImmunology, vol. 1, no. 6, 1 September 2012 (2012-09-01), pages 957-958, (B2)

Kohrt et al - supplementary material (B2)

Kohrt et al., (2011). Blood 117(8), 2423-2432 (B2)

Roch Houot et al: "Targeting immune effector cells to promote antibody-induced cytotoxicity in cancer immunotherapy", Trends in immunology, vol. 32, no. 11 , pages 510-516, (B2)

US-A1- 2014 363 442 (B2)

WO-A1-2011/034969 (B2)

WO-A1-2013/109752 (B2)

WO-A1-2015/191861 (B2)

WO-A1-2016/023040 (B2)

WO-A1-2016/063233 (B2)

WO-A1-2017/027422 (B2)

CHRISTOPHER LUCIDO ET AL: "CD137 Enhancement of HPV Positive Head and Neck Squamous Cell Carcinoma Tumor Clearance", VACCINES, vol. 2, no. 4, 10 December 2014 (2014-12-10), pages 841-853, XP055478079, DOI: 10.3390/vaccines2040841 (B1)